Authors
Loading...
Randomized trial analyzes IGF2-H19 locus as a biomarker for oral cancer, suggesting its diagnostic potential.
Stojković et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: